California Cancer Reporting System Standards, Volume III

 

Tum Markers 2

IDENTIFIERS

CCR ID

NAACCR ID

E1162

1160

DESCRIPTION

Field to record progesterone receptor for breast, prostatic specific antigen for prostate, and HCG for testis. If a hospital is collecting tumor markers on other sites, they may report in this field.

LEVELS

Tumor

Admission

LENGTH

1

ALLOWABLE VALUES

er103 Tum Markers 2

Codes
0 Test Not Done (includes cases diagnosed at autopsy)
1 Test Done, Results Positive/Elevated
2 Test Done, Results Negative/Normal
3 Test Done, Results Borderline or Undetermined Whether Positive or Negative
4

Range 1     < 5,000 mIU/ml

5

Range 2         5,000 - 50,000 mIU/ml

6

Range 3     >50,000 mIU/ml

8

Test Ordered, Results Not in Chart

9 Unknown  If Test Done or Ordered; No Information (includes death-certificate-only cases).
 
For all other sites for which Tumor Marker 2 is not collected:
  9 is not applicable for cases diagnosed after January 1, 2004.
  For testicular cancer, the valid codes are 0, 2, 4-6, 8, 9.

SOURCE

Tumor Marker 2 (CCR Identifier E1162)

If the transmitted value is numeric, then just load it with no conversion.

Otherwise, convert it to 9.

UPDATE

None at Admissions.

For TU Tum Markers, examine all Admissions records for that tumor.

For each marker (considered separately) select from among the values at the Admissions levels in the following order: 1, 2, 3, 8, 0, and 9 (last).

For testis, select values at the Admissions level as follows: 6, 5, 4, 2, 8, 0, and 9.

CONSOLIDATED DATA EXTRACT

Yes, extract from the tumor record.

For SEER EXTRACT:

If Date of Diagnosis < 1990, then generate 9

If Date of Diagnosis =1990-2003 and Primary Site=500-509 and Type of Reporting Source=6 then generate 0

If Date of Diagnosis =1990-2003 and Primary Site=500-509 and Type of Reporting Source=7 then generate 9

If Date of Diagnosis = 1990-2003 and Primary Site=500-509 and Type of Reporting Source <> 6 or 7 then take the tumor level value

If Date of Diagnosis = 1998-2003 and Primary Site=619 or 620-629 and Type of Reporting Source=6 then generate 0

If Date of Diagnosis = 1998-2003 and Primary Site=619 or 620-629 and Type of Reporting Source=7 then generate 9

If Date of Diagnosis = 1990-1997 and Primary Site <> 500-509 then generate 9

If Date of Diagnosis = 1998-2003 and Primary Site=619 or 620-629 and Type of Reporting Source <> 6 or 7 then take tumor level value

If Date of Diagnosis = 1998-2003 and Primary Site <> 500-509 or 619 or 620-629 then generate 9

If Date of Diagnosis > 2003 then generate blank

References: SEER IF65 & 67

INTERFIELD EDITS

IF757 Tumor Marker 2, Primary Site, Date of Diagnosis

HISTORICAL CHANGES

3/4/04 Tumor Markers 1-3 are required by SEER and the CCR for cases diagnosed prior to 2004. For cases diagnosed January 1, 2004 forward, Tumor Markers 1-3 will be collected in the Collaborative Staging Site Specific Factor fields.
3/5/07 Added SEER Extract logic so documentation is recorded and clarified to match SEER edit 66 & 68 (CCR database contains various values for different sites based on the College's allowance of tumor markers for other sites and diagnosis years. Also, hospitals have used these fields to capture tumor markers.). Added edit IF 757 to enforce the allowable values for testes cases.
2010 Data Changes: CCR name (Tum Markers 2) changed to NAACCR name.  Since Tumor Markers are now captured in the CSv2 SSF fields, it is optional for registrars to enter in the data in the old Tumor Marker fields.  Vendors can convert any existing Tumor Marker fields to the new CSv2 SSF fields.